
|Articles|July 8, 2008
Thermage to buy Reliant for $87.5 million plus debt
New York - Thermage, which makes an anti-aging skin tightening device, announced it will buy Reliant Technologies for $87.5 million in stock and cash, according to the Associated Press.
Advertisement
New York
- Thermage, which makes an anti-aging skin tightening device, announced it will buy Reliant Technologies for $87.5 million in stock and cash, according to the Associated Press.
Thermage is set to pay $25 million in cash and issue $23.6 million shares valued at $62.5 million. Thermage also agreed to assume $7 million in debt and provide $5 million of bridge financing to Reliant.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
2
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
3
Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT
4
French Early Access Data on Dupilumab in Pediatric Atopic Dermatitis
5


















